Results 161 to 170 of about 8,117 (271)
Real-world effectiveness of benralizumab in US subspecialist-treated adults with severe asthma: Findings from CHRONICLE [PDF]
, 2023 Reynold A. Panettieri +8 more
openalex +1 more source
International Journal of Molecular SciencesThe most promising treatment options for severe uncontrolled asthma (SUA) have emerged in recent years with the development of monoclonal antibodies for blocking selective targets responsible for the underlying inflammation, such as mepolizumab and ...
S. Rojo-Tolosa +7 more
semanticscholar +1 more source
A Comprehensive Review on Drug Profile of Benralizumab
This comprehensive review explain that the drug profile of benralizumab, a monoclonal antibody approved by the FDA for the management of severe eosinophilic asthma and other eosinophilic conditions. Highlighting asthma as a chronic inflammatory disorder characterized by eosinophilic excess, the review classifies treatment options including ...
+5 more sources
Effectiveness of benralizumab in patients with severe asthma [PDF]
Journal of Allergy and Clinical Immunology, 2020 Mika Saigusa +14 more
openaire +2 more sources
Rapid and sustained effects of a single dose of benralizumab on chronic eosinophilic pneumonia
Respiratory Medicine Case Reports, 2020 Chronic eosinophilic pneumonia (CEP) is an eosinophilic inflammatory disease of unknown etiology, and oral corticosteroid (OCS) is commonly used for its treatment. Approximately half of CEP cases relapse secondary to reduction or termination of OCS. A 43-
Takehiro Izumo +10 more
doaj
M24 3-year real world outcomes with benralizumab for severe eosinophilic asthma [PDF]
, 2023 H. P. Palmer +5 more
openalex +1 more source
Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma
, 2018 Gary T. Ferguson +7 more
openalex +2 more sources
Biologic Pathways For Chronic Spontaneous Urticaria And Their Regulation By Benralizumab
, 2022 Debajyoti Ghosh +4 more
openalex +1 more source